3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Sleep Wake Disorders
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Overweight
1
Obesity
1
Neoplasms
1
Motor Activity
1
Lung Neoplasms
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Kidney Neoplasms
1
Hematologic Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Castration-Resistant Prostate Cancer (CRPC)
1
Carcinoma, Renal Cell
1
Interventions
Rituximab
15
Cyclophosphamide
15
Prednisone
11
Doxorubicin
10
Vincristine
7
Lenalidomide
7
ibrutinib
6
polatuzumab vedotin
4
obinutuzumab
4
glofitamab
4
fludarabine
4
Oxaliplatin
4
Magnetic Resonance Spectroscopy
4
Gemcitabine
4
venetoclax
3
fludarabine phosphate
3
Whole-Body Irradiation
3
Specimen Handling
3
R-CHOP protocol
3
Etoposide
3
Cyclosporine
3
Biopsy
3
zanubrutinib
2
prednylidene
2
pembrolizumab
2
deltacortene
2
acalabrutinib
2
Prednisolone
2
Mycophenolic Acid
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large B-Cell, Diffuse
×
Counseling
×
30 days
×
Clear all
No trials found.